Versiti Blood Health
Quick facts
Marketed products
- efanesoctacog alpha · Hematology
Efanesoctacog alpha is a recombinant fusion protein that bridges Factor IXa and Factor X to restore the intrinsic tenase complex activity in patients with hemophilia B.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Versiti Blood Health
What are Versiti Blood Health's marketed drugs?
Top marketed products include efanesoctacog alpha.
Related
- efanesoctacog alpha · Hematology
- Sector hub: All tracked pharma companies